Analysts at HC Wainwright lowered their Q1 2025 EPS estimates for shares of CG Oncology in a research report issued to clients and investors on Monday, March 31st. HC Wainwright analyst A. Maldonado ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback